Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a university hospital in Tunisia

Microbial Drug Resistance

Volumn 14, Issue 4, 2008, Pages 289-292

  Mansour, Wejdene ^a,b   Poirel, Laurent ^a   Bettaieb, Dalia ^a,b   Bouallegue, Olfa ^b   Boujaafar, Noureddine ^b   Nordmann, Patrice ^a,c  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL ENZYME; CARBAPENEM; CEFTAZIDIME; COLISTIN; GENTAMICIN; IMIPENEM; OXACILLINASE; RIFAMPICIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; GENE INSERTION SEQUENCE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; TUNISIA; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DNA TRANSPOSABLE ELEMENTS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; TUNISIA;

ACINETOBACTER BAUMANNII;

EID: 57749174022     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0838     Document Type: Article

References (21)

1. Bergogne-Bérézin, E., and K.J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
2. Bou, G., G. Cervero, M.A. Dominguez, C. Quereda, and J. Martinez-Beltran. 2000. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in Acinetobacter baumannii is not due solely to the presence of β-lactamases. J. Clin. Microbiol. 38:3299-3305.
3. [CLSI] Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement M100-S18. Clinical and Laboratory Standards Institute, Baltimore, MD.
4. OXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:1530-1533.
5. Dalla-Costa, L., J.M. Coelho, H.A.P.H.M. Souza, M.E.S. Castro, C.J.N. Stier, K.L. Bragagnolo, A. Rea-Neto, S.R. Penteado-Filho, D.M. Livermore, and N. Woodford. 2003. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curtiba, Brazil. J. Clin. Microbiol. 41:3403-3406.
6. Donald, H.M., W. Scaife, S.G. Amyes, and H.K. Young. 2000. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 44:196-199.
7. Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273.
8. Héritier, C., A. Dubouix, L. Poirel, N. Marty, and P. Nordmann. 2005. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolyzing oxacillinase OXA-58. J. Antimicrob. Chemother. 55:115-118.
9. Héritier, C., L. Poirel, T. Lambert, and P. Nordmann. 2005. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:3198-3202.
10. Kieser, T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36.
11. Lopez-Otsoa, F., L. Gallego, K.J. Towner, L. Tysall, N. Woodford, and D.M. Livermore. 2002. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J. Clin. Microbiol. 40:4741-4743.
12. Naas, T., M. Levy, C. Hirschauer, H. Marchandin, and P. Nordmann. 2005. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J. Clin. Microbiol. 43:4826-4829.
13. Paton, R., R.S. Miles, J. Hood, and S.G.B. Amyes. 1993. ARI-1: β-lactamase mediated imipenem resistance. Int. J. Antimicrob. Agents 2:81-88.
14. Poirel, L., and P. Nordmann. 2005. Acquired carbapenem-hydrolyzing β-lactamases and their genetic support. Curr. Pharm. Biotechnol. 3:117-127.
15. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
16. Poirel, L., S. Figueiredo, V. Cattoir, A. Carattoli, and P. Nordmann. 2008. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob. Agents Chemother. 52:1252-1256.
17. Poirel, L., E. Lebessi, C. Héritier, A. Patsoura, M. Foustoukou, and P. Nordmann. 2006. Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a pediatric hospital in Greece. Clin. Microbiol. Infect. 12:1138-1141.
18. Poirel, L., W. Mansour, O. Bouallegue, and P. Nordmann. 2008. Carbapenem-resistant Acinetobacter baumannii isolates producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97 from Tunisia. Antimicrob. Agents Chemother. 52:1613-1617.
19. Poirel, L., S. Marqué, C. Héritier, C. Segonds, G. Chabanon, and P. Nordmann. 2005. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:202-208.
20. Segal, H., E.C. Nelson, and B.G. Elisha. 2004. Genetic environment of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob. Agents Chemother. 48:612-614.
21. Tenover, F., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.